What You Should Know:
- Phenomix Sciences, a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces a new partnership to advance precision medicine in obesity with InformedDNA, the nation’s leading applied genomics solutions company.
- The collaboration integrates Phenomix’s MyPhenomeTM genetic obesity test with InformedDNA’s DNAimpactTM precision health platform, broadening access to genetics-based weight management care for
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Honeywell, Salesforce Partner to Improve Outcomes in Life Sciences
What You Should Know:
- Honeywell (Nasdaq: HON) today announced the expansion of its strategic partnership with Salesforce, Inc. to deliver a comprehensive platform of software solutions for the life sciences industry.
- The platform—which includes Honeywell’s TrackWise Quality, Salesforce Life Sciences Cloud, Agentforce, and other solutions—will help pharmaceutical and medical technology companies deliver critical medications and healthcare devices to patients more quickly, safely, and
Read More
Myriad Genetics, Flatiron Health Integrates Genetic Testing into OncoEMR
What You Should Know:
- Myriad Genetics, a leader in genetic testing and precision medicine, has announced a collaboration with Flatiron Health, a healthcare technology company focused on oncology solutions, to integrate Myriad's MyRisk® Hereditary Cancer Test into Flatiron's OncoEMR® platform.
- This integration will streamline the process of ordering and reviewing genetic testing results for clinicians within Flatiron's network of community-based cancer care providers.
Improving
Read More
Best Practices for Conquering Data Management Challenges in the Pharma Industry
Managing data effectively can be challenging in any context. But it's especially difficult in an industry like pharmaceuticals, due both to the sensitivity of the data and the severity of consequences that result from data management mistakes.
What can pharma companies do to implement an effective data management strategy? There are no simple answers, but as I explain below, there are best practices that can help optimize the way pharmaceutical businesses collect, integrate, analyze and store
Read More
Cytovale Secures $100M to Expand Commercialization of FDA-Cleared Sepsis Test
What You Should Know:
- Cytovale, a medical diagnostics company revolutionizing early disease detection secures $100M in Series D funding round led by Sands Capital with participation from new investor Canada Pension Plan Investment Board (CPP Investments) and existing investors.
- The investment will fuel the expansion of Cytovale's innovative sepsis diagnostic, IntelliSep, to more hospital emergency departments (EDs) and health systems nationwide.
IntelliSep:
Read More
IQIVIA Launches GenAI Assistant for Life Sciences
What You Should Know:
- IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today introduces IQVIA AI Assistant, a generative AI technology that enables a step-change enhancement in how life science customers receive timely and powerful insights.
- IQVIA AI Assistant is a user-friendly, conversational text interface that provides immediate and intuitive analytic
Read More
Leveraging Technology to Improve Pharmaceutical Oversight and Patient Safety
In a time when healthcare is always changing, the pharmaceutical sector is under more pressure to ensure patient safety while maintaining compliance with stringent regulatory standards. As the complexity of pharmaceutical delivery rises, technology has become ever more crucial in tracking and safeguarding pharmacological products.
One especially remarkable development in this area is PharmaWatch, a real-time tracking system that enhances pharmaceutical control and enables healthcare
Read More
clock.bio Raises $5.3M to Decode Human Rejuvenation, Develop Anti-Aging Therapies
What You Should Know:
- clock.bio, a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M in seed funding to advance its groundbreaking research on human rejuvenation.
- The seed funding round was led by LocalGlobe, with participation from BlueYard Capital, Onsight Ventures, and Dr. Jonathan Milner, the Founder of Abcam.
Decoding the Secrets of Cellular Rejuvenation
clock.bio has developed a proprietary aging model
Read More
Advancing Drug Discovery with Quantum Computing and Supercomputer Tech
McKinsey & Company estimates it takes up to 12 years to introduce a new drug to the market – a lengthy timeline comprised of many factors including technology limitations, regulatory requirements, and patient recruitment and retention. Scientific innovation and clinical trials are increasingly complex, generating more data than ever. Researchers are facing difficulties managing the volume and variety of data, turning to artificial intelligence, machine learning and advanced data architecture
Read More
Pharmacogenomic Testing in Mental Health: The Need for a Broader Approach
What if we advised people to wear seatbelts only on certain days or when driving on specific highways? Clearly, this would result in real and avoidable harm. Unfortunately, something similar has happened to millions of patients who underwent pharmacogenomics (PGx) testing to aid in selecting drugs and doses for treating depression or anxiety, tailored to their unique genetics, without considering the broader implications. In mental health treatment, patients often endure multiple therapies
Read More
